市场调查报告书
商品编码
1384300
质子治疗系统市场 - 按设定类型(单室、多室)、按适应症(乳腺癌、肺癌、前列腺癌、胃肠癌、脑癌)、按最终用途(医院、质子治疗中心) - 2032 年全球预测Proton Therapy Systems Market - By Set-up Type (Single Room, Multiple Room), By Indication (Breast Cancer, Lung Cancer, Prostate Cancer, Gastro-intestinal Cancer, Brain Cancer), By End-use (Hospitals, Proton Therapy Centers) - Global Forecast to 2032 |
由于技术进步导致结果改善,质子治疗系统市场规模预计 2023 年至 2032 年CAGR将超过 10.5%。例如,笔形束扫描和调强质子治疗提高了治疗精度并扩大了可治疗病症的范围。 2023 年 10 月,Mevion Medical Systems 在美国和加拿大推出了“Mevion Capital”,这是一种用于癌症放射治疗的紧凑型质子治疗系统。
此外,由于辐射引起的併发症风险较低,并且对健康组织的损害最小,因此质子治疗成为儿童和成人患者的首选。这导致全球对质子治疗系统的采用和需求增加。癌症患者群体的扩大和支持性报销政策进一步影响了市场的成长轨迹。
整个质子治疗系统市场根据设定类型、适应症、最终用途和地区进行划分。
预计到 2032 年,多房间设置类型细分市场将出现大幅增长,因为它们能够有效地治疗更多患者、减少等待时间并提供更好的医疗保健体验。此类设施配备了多个治疗室,使医疗保健提供者能够满足更多患者的需求。随着医疗机构持续投资扩大质子治疗能力,产品需求将会增加。
质子治疗中心最终用途部分预计到 2032 年将产生大量收入,因为这些专用中心为患者提供全面的质子治疗服务,确保最高品质的护理。质子治疗中心在对抗癌症方面发挥着至关重要的作用,而且其数量正在增加。他们提供一系列的治疗选择,并且通常配备最先进的技术,使他们成为市场扩张的关键贡献者。
由于中国、日本和韩国等国家癌症发病率的不断上升、医疗基础设施的发展以及医疗支出的增加,亚太地区质子治疗系统市场将在 2023 年至 2032 年录得强劲的CAGR。为了加强癌症治疗选择,亚太地区质子治疗中心的建立激增。这些中心配备了最新的质子治疗系统,方便该地区的人们获得先进的癌症治疗。
Proton therapy system market size is expected to record more than 10.5% CAGR from 2023 to 2032 due to the technological advancements that lead to improved results. For instance, pencil beam scanning and intensity-modulated proton therapy have enhanced treatment precision and expanded the range of treatable conditions. In October 2023, Mevion Medical Systems launched 'Mevion Capital' in US and Canada, a compact proton therapy system for use in radiation therapy of cancer.
Furthermore, the lower risk of radiation-induced complications and minimal damage to healthy tissues make proton therapy a preferred choice for both pediatric and adult patients. This has led to increased adoption and demand for proton therapy systems worldwide. The expanding pool of cancer patients and supportive reimbursement policies further influence the market growth trajectory.
The overall proton therapy systems market is divided based on set-up type, indication, end-use, and region.
The multiple room set-up type segment is predicted to witness substantial growth through 2032 due to their ability to treat more patients efficiently, reducing waiting times and providing a better healthcare experience. Such facilities are equipped with multiple treatment rooms and enable healthcare providers to cater to a larger patient population. As healthcare facilities continue to invest in expanding their proton therapy capabilities, the product demand will increase.
The proton therapy center end-use segment is anticipated to generate massive revenues by 2032 as these dedicated centers offer comprehensive proton therapy services to patients, ensuring the highest quality of care. Proton therapy centers are playing a crucial role in the fight against cancer, and their numbers are on the rise. They offer a range of treatment options and are often equipped with state-of-the-art technology, making them a key contributor to the market expansion.
Asia Pacific proton therapy systems market will record strong CAGR from 2023 to 2032 attributed to the growing prevalence of cancer, increasing healthcare infrastructure development, and rising medical expenditure in countries such as China, Japan, and South Korea. With a focus on enhancing cancer treatment options, the APAC region is witnessing a surge in the establishment of proton therapy centers. These centers are equipped with the latest proton therapy systems, facilitating access to advanced cancer treatments for the population in the region.